What does it really take to build a sustainable research ecosystem?
Not a grant. Not a building. Not even a world-class principal investigator.
Innovation does not happen in isolation; it flourishes in ecosystems. A sustainable research ecosystem is the connected system of institutions, people, policies, and infrastructure that enables research to be conducted reliably, at scale, and over time. While individual research centers may achieve short-term success, long-term impact depends on how well those centers are embedded within broader networks, governance structures, quality systems, and workforce pipelines.
Across the globe, countries that have treated research as essential national infrastructure, something to be governed, coordinated, and quality-assured, have strengthened public health, improved local decision-making, and generated sustained economic value.
The Pitfalls of Isolated Investments
For many years, efforts to build research capacity in low- and middle-income settings, including parts of Africa, have focused on creating individual “centers of excellence.” These site-specific investments are often well intentioned, but they tend to produce fragile excellence, pockets of capability that struggle to survive once external funding ends.
A state-of-the-art facility means little without a steady pipeline of skilled researchers, managers, and technicians. When training is limited to individual projects rather than embedded in national systems, talent often migrates elsewhere, a familiar symptom of brain drain.
Isolation also limits impact. A single site operating in a silo cannot easily support multi-site studies, share data efficiently, or generate the scale often required for generalizable findings and regulatory-grade evidence. By contrast, countries that invest in research networks amplify the value of individual sites. Australia’s experience illustrates this, the Australian Clinical Trials Alliance (ACTA) links trial networks and coordinating centers nationwide, enabling collaboration, standardization, and efficient multi-site studies (1).
In many African countries, research spending remains well below the global average, contributing to stop–start capacity when externally funded projects conclude (2). Without integration into national budgets, policies, and regulatory systems, standalone projects frequently struggle to endure. A research site without an ecosystem is like a tree planted in barren soil, it may survive briefly, but it will never form a forest.
Global Success Stories: How Systems Are Built
International experience shows that sustainable research ecosystems are deliberately engineered over time.
China’s transformation is one of the most striking examples. Two decades ago, its research output was modest. Today, China invests approximately 2.56% of GDP in research and development (2022) (3). This investment was distributed across a nationwide network of universities, public research institutes, and industry laboratories. Crucially, infrastructure spending was matched with large-scale workforce development and talent recruitment, contributing to rising research output and international competitiveness (4).
South Korea followed a similar systems logic, aligning research investment with long-term industrial strategy. With research and development expenditure exceeding 4% of GDP in recent years (5), the country prioritized strategic sectors such as life sciences and advanced manufacturing. Public investment, combined with strong linkages between government, universities, and industry, supported translation from research to commercialization and embedded innovation within national health and economic systems (6).
Singapore offers a compact but instructive case. With a limited population and no natural resources, it adopted a whole-of-government approach to research. National governance structures set priorities and funded multi-year research plans, while agencies such as the Agency for Science, Technology and Research (A*STAR) coordinated basic and applied research. Physical clustering in hubs like Biopolis enabled collaboration through co-location and shared infrastructure, while sustained investment in talent development created credible career pathways for local researchers (7).
Australia’s experience underscores the importance of governance and quality reform alongside funding. The establishment of the Medical Research Future Fund (MRFF), a long-term national investment now exceeding AUD 24 billion, provided stable financing insulated from short political cycles (8). In parallel, national efforts to strengthen consistency in clinical trials governance and ethics review reduced fragmentation and improved quality, making Australia a more attractive destination for global clinical research.
Across these diverse contexts, the lesson is consistent, funding matters, but governance, coordination, quality systems, and workforce development determine whether funding translates into sustainable impact.
The Economic Case: Research as Investment
The economic case for sustained research investment is strong. Research ecosystems drive productivity, enable innovation, and support the growth of high-value industries. Analysis suggests that if African countries collectively increased research and development spending to 1% of GDP over time, the resulting innovation could unlock between USD 60–70 billion annually across sectors such as agriculture, digital technology, and manufacturing (9).
Beyond aggregate growth, research investment improves productivity. The International Monetary Fund (IMF) analysis indicates that a permanent increase in a country’s stock of basic research is associated with measurable gains in long-term productivity (10). The experience of high-income economies illustrates the scale of potential returns, in the United States, the bioscience sector alone generates over USD 3 trillion in economic output and supports millions of jobs, demonstrating how research-intensive industries deliver both health and economic benefits (11).
While African contexts differ, the underlying principle holds. Countries that invest consistently in research ecosystems are better positioned to develop local solutions, reduce dependence on external innovation, and participate more fully in global knowledge production.
Implications for Africa: Adapting Lessons to Local Realities
For Africa, the challenge is not to replicate global models wholesale, but to adapt their underlying principles to local realities.
First, sustainability requires greater national ownership of research. Long-term capacity cannot rely primarily on external funding. Integrating research into national health, education, and development plans as well as committing to incremental, predictable public investment, creates the foundation for continuity beyond donor cycles.
Second, networks must be prioritized over isolated sites. No single institution or country can address every scientific challenge alone. Pan-African collaboration enables scale, shared learning, and efficient use of scarce expertise. Organizations such as the Africa Clinical Research Network (ACRN) and the African Academy of Sciences (AAS) play important roles in connecting sites, supporting common standards, and reducing duplication across borders (12).
Third, regulatory and ethics capacity must keep pace with research ambition. Fragmented or inconsistent regulatory processes remain a major bottleneck for multi-country studies. The African Medicines Agency (AMA) treaty entered into force in November 2021, signaling momentum toward greater regulatory coordination across the continent (13). Its impact, however, will depend on sustained national investment, implementation capacity, and alignment with ethics oversight, data governance, and laboratory standards such as Good Laboratory Practice (GLP).
Finally, people remain the limiting factor. Africa’s youthful population represents a significant opportunity, but training must be scaled and linked to credible career pathways. Universities, ministries, and the private sector all have roles to play in creating “pull” factors, research units, industry research and development roles, and leadership opportunities that enable skilled researchers to build long-term careers on the continent.
Conclusion: From Projects to Ecosystems
The difference between sporadic research gains and lasting impact lies in systems. Site-by-site investments can deliver short-term results, but without networks, governance, quality systems, and workforce development, they rarely endure.
Global experience, from China and South Korea to Singapore and Australia, show that sustainable research ecosystems are built through long-term vision, coordinated investment, and institutional reform. For Africa, moving beyond fragmented, short-term approaches toward a shared compact is essential, predictable public financing, credible and efficient regulation, shared quality standards, and deeper South–South collaboration.
Pan-African coordination platforms can support this shift by aligning standards, strengthening operational readiness, and facilitating collaboration across countries. Ultimately, sustainability depends on collective commitment. When research ecosystems are treated as national and regional infrastructure, they not only improve health outcomes but also strengthen economic resilience and ensure that African institutions play a larger role in shaping global science.
References
- https://clinicaltrialsalliance.org.au/ [Internet]. 2026 [cited 2026 Feb 3]. ACTA – Australian Clinical Trials Alliance – Better health through best evidence. Available from: https://clinicaltrialsalliance.org.au/
- World Economic Forum [Internet]. 2023 [cited 2026 Feb 3]. African countries spend on average 0.45% of their GDP on R&D, far below the global average of 1.7%. Available from: https://www.weforum.org/stories/2023/11/innovative-approaches-for-unlocking-research-and-development-funding-in-africa/
- Research and development expenditure (% of GDP) – China | Data [Internet]. [cited 2026 Feb 3]. Available from: https://data.worldbank.org/indicator/GB.XPD.RSDV.GD.ZS?locations=CN
- Huang Y, Cheng X, Tian C, Jiang X, Ma L, Ma Y. Talent hat, cross-border mobility, and career development in China [Internet].arXiv; 2024 [cited 2026 Feb 5]. Available from: http://arxiv.org/abs/2403.00107
- World Bank Open Data [Internet]. [cited 2026 Feb 3]. World Bank Open Data. Available from: https://data.worldbank.org
- Seoul to Accelerate Industry Transition to AI, Launching AX Innovation Center and AI Graduate School Committee | Seoul Metropolitan Government [Internet]. 2025 [cited 2026 Feb 3]. Available from: https://english.seoul.go.kr/seoul-to-accelerate-industry-transition-to-ai-launching-ax-innovation-center-and-ai-graduate-school-committee/
- Biopolis: Ten years on – A*STAR Research [Internet]. [cited 2026 Feb 3]. Available from: https://research.a-star.edu.sg/articles/features/biopolis-ten-years-on/
- Australian Government Department of Health D and A. Medical Research Future Fund [Internet]. Australian Government Department of Health, Disability and Ageing; 2025 [cited 2026 Feb 3]. Available from: https://www.health.gov.au/our-work/mrff
- Agency E. Ecofin Agency. [cited 2026 Feb 3]. Africa’s Research & Development Deficit Masks a $60 Billion Industrial Opportunity. Available from: https://www.ecofinagency.com/insights/0709-48471-africa-s-research-development-deficit-masks-a-60-billion-industrial-opportunity
- IMF [Internet]. 2021 [cited 2026 Feb 3]. Why Basic ScienceMatters forEconomic Growth. Available from: https://www.imf.org/en/blogs/articles/2021/10/06/blog-ch3-weo-why-basic-science-matters-for-economic-growth
- AZBio. New Report Finds Bioscience Sector Generates Over $3 Trillion for U.S. Economy |AZBio[Internet]. 2024 [cited 2026 Feb 3]. Available from: https://www.azbio.org/new-report-finds-bioscience-sector-generates-over-3-trillion-for-u-s-economy
- EurekAlert! [Internet]. [cited 2026 Feb 5]. Strengthening Africa’s clinical trial capacity through an online platform. Available from: https://www.eurekalert.org/news-releases/882470
- African Medicines Agency (AMA) | AUDA-NEPAD [Internet]. [cited 2026 Feb 3]. Available from: https://www.nepad.org/microsite/african-medicines-agency-ama